|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
10,820,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
401,241 |
Avg
Vol: |
400,142 |
52
Week Range: |
$115.55 - $119.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
14,458 |
Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2016-11-15 |
4 |
D |
$65.88 |
$253,111 |
D/D |
(3,842) |
43,702 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2016-11-15 |
4 |
OE |
$17.17 |
$154,530 |
D/D |
9,000 |
47,544 |
|
- |
|
Mcginley Michael J |
Pres., Biologic. & Pharm. |
|
2016-11-15 |
4 |
OE |
$17.17 |
$17 |
D/D |
1 |
116,237 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2016-11-11 |
4 |
OE |
$4.40 |
$900,702 |
D/D |
96,016 |
116,236 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2016-11-10 |
4 |
D |
$62.50 |
$105,438 |
D/D |
(1,687) |
38,149 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2016-11-10 |
4 |
OE |
$17.17 |
$103,020 |
D/D |
6,000 |
39,836 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2016-11-07 |
4 |
S |
$61.00 |
$305,000 |
D/D |
(5,000) |
8,266 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2016-11-07 |
4 |
OE |
$7.36 |
$36,800 |
D/D |
5,000 |
13,266 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2016-11-07 |
4 |
S |
$59.76 |
$601,051 |
D/D |
(9,998) |
20,220 |
|
- |
|
Napolitano Jason A |
COO, CFO, EVP and Secretary |
|
2016-09-01 |
4 |
S |
$52.52 |
$262,642 |
D/D |
(5,000) |
38,544 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-08-29 |
4 |
S |
$51.60 |
$709,269 |
I/I |
(13,668) |
8,432 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-08-26 |
4 |
S |
$51.60 |
$326,731 |
I/I |
(6,332) |
12,100 |
|
- |
|
Mcmahon John |
VP, Fin. Oper. & Controller |
|
2016-08-24 |
4 |
S |
$51.30 |
$7,028 |
D/D |
(137) |
0 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2016-08-09 |
4 |
S |
$52.55 |
$246,864 |
D/D |
(4,698) |
8,160 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2016-08-09 |
4 |
OE |
$8.35 |
$39,228 |
D/D |
4,698 |
12,858 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-08-03 |
4 |
AS |
$47.34 |
$1,454,368 |
D/D |
(30,720) |
110,000 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-08-02 |
4 |
AS |
$43.95 |
$703 |
D/D |
(16) |
140,720 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-07-29 |
4 |
AS |
$43.95 |
$879 |
D/D |
(20) |
140,736 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-07-20 |
4 |
AS |
$44.02 |
$166,362 |
D/D |
(3,779) |
140,756 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-07-18 |
4 |
AS |
$44.31 |
$242,134 |
D/D |
(5,465) |
144,535 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-07-08 |
4 |
AS |
$42.37 |
$423,666 |
D/D |
(10,000) |
150,000 |
|
- |
|
Napolitano Jason A |
COO, CFO, EVP and Secretary |
|
2016-07-07 |
4 |
AS |
$41.00 |
$820,000 |
D/D |
(20,000) |
43,544 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-07-06 |
4 |
AS |
$40.27 |
$240,008 |
D/D |
(5,960) |
160,000 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-07-01 |
4/A |
AS |
$38.94 |
$546,664 |
D/D |
(14,040) |
165,960 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2016-07-01 |
4 |
S |
$38.94 |
$546,664 |
D/D |
(14,040) |
165,960 |
|
- |
|
465 Records found
|
|
Page 14 of 19 |
|
|